| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/31/2022 | Atea Pharmaceuticals, Inc. | AVIR | Grant | Stock Option (Right to Buy) | 378k | $7.14 | $2.7M | | 01/31/2022 |
| 06/28/2021 | Kezar Life Sciences, Inc. | KZR | Grant | Stock Option (Right to Buy) | 26k | $5.59 | $145.3k | | 06/28/2021 |
| 01/29/2021 | Atea Pharmaceuticals, Inc. | AVIR | Grant | Stock Option (Right to Buy) | 640k | $73.00 | $46.7M | | 01/29/2021 |
| 11/03/2020 | Atea Pharmaceuticals, Inc. | AVIR | Conversion | Common Stock | 750k | $0.00 | $0 | Held by JPM Partners LLC | 11/03/2020 |
| 11/03/2020 | Atea Pharmaceuticals, Inc. | AVIR | Conversion | Series A Convertible Preferred Stock | 750k | $0.00 | $0 | Held by JPM Partners LLC | 11/03/2020 |
| 06/24/2020 | Kezar Life Sciences, Inc. | KZR | Grant | Stock Option (Right to Buy) | 8.9k | $5.60 | $49.8k | | 06/24/2020 |
| 06/25/2019 | Kezar Life Sciences, Inc. | KZR | Grant | Stock Option (Right to Buy) | 8.9k | $7.63 | $67.9k | | 06/25/2019 |
| 06/25/2018 | Kezar Life Sciences, Inc. | KZR | Conversion | Common Stock | 52.6k | $0.00 | $0 | By JPM Partners, LLC | 06/25/2018 |
| 06/25/2018 | Kezar Life Sciences, Inc. | KZR | Conversion | Common Stock | 35.3k | $0.00 | $0 | By JPM Partners, LLC | 06/25/2018 |
| 06/25/2018 | Kezar Life Sciences, Inc. | KZR | Conversion | Series A Convertible Perferred Stock | 52.6k | $0.00 | $0 | By JPM Partners, LLC | 06/25/2018 |
| 06/25/2018 | Kezar Life Sciences, Inc. | KZR | Conversion | Series B Convertible Perferred Stock | 35.3k | $0.00 | $0 | By JPM Partners, LLC | 06/25/2018 |